Biodexa Pharmaceuticals Plc

NASDAQ: BDRX
Nasdaq Stock Market
Healthcare Biotechnology
Global Rank
#36177
Country Rank
#880
Market Cap
21.1 M
Price
7.3
Change (%)
7.01%
Volume
16,726

Biodexa Pharmaceuticals Plc's latest marketcap:

21.1 M

As of 08/01/2025, Biodexa Pharmaceuticals Plc's market capitalization has reached $21.1 M. According to our data, Biodexa Pharmaceuticals Plc is the 36177th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 21.1 M
Revenue (ttm) 104,895
Net Income (ttm) -7,172,277
Shares Out 2.89 M
EPS (ttm) -144.81
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date 09/29/2025
Market Cap Chart
Data Updated: 08/01/2025

Biodexa Pharmaceuticals Plc's yearly market capitalization.

Biodexa Pharmaceuticals Plc has seen its market value drop from $77.6 M to $21.1 M since 2015, representing a total decrease of 72.81% and an annual compound decline rate (CAGR) of 12.70%.
Date Market Cap($) Change (%) Global Rank
08/01/2025 $21.1 M -3.54% 36177
12/31/2024 $23.52 M -66.49% 42899
12/29/2023 $70.2 M 64.68% 38528
12/30/2022 $42.63 M -67.88% 38730
12/31/2021 $132.72 M -43.67% 34548
12/31/2020 $235.62 M 1360.79% 28734
12/31/2019 $16.13 M 246.87% n/a
12/31/2018 $4.65 M -81.49% n/a
12/29/2017 $25.12 M -62.07% n/a
12/30/2016 $66.24 M -14.64% n/a

Company Profile

Biodexa Pharmaceuticals Plc was founded in 2000 in United Kingdom. on the Nasdaq Stock Market. With 13 employees, it focuses on Healthcare and aims to drive innovation in Biotechnology.

Frequently Asked Questions

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.